1,586
Participants
Start Date
February 28, 2007
Primary Completion Date
June 30, 2009
Study Completion Date
September 30, 2009
Laerdal Q-CPR /technology
For the first three to six months, participating EMS agencies will have defibrillators with automated, real-time feedback inactivated. During this period, the baseline rate of ROSC (and secondary outcomes) will be collected. At the end of this baseline period, EMS agencies will be randomized to one of two interventions, with randomization stratified within site by agency, station, or device. All clusters will cross-over to the opposite feedback strategy at least once during the intervention phase.
University of Pittsburgh, Pittsburgh
University of Washington, Seattle
The Ottawa Hospital, Thunder Bay
Collaborators (1)
National Heart, Lung, and Blood Institute (NHLBI)
NIH
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
The Institute of Circulatory and Respiratory Health (ICRH)
UNKNOWN
Defence Research and Development Canada
INDUSTRY
University of Washington
OTHER